碳酸氢钠对院外心脏骤停患者的影响:随机对照试验与倾向评分研究的系统评价与Meta分析
该系统评价与Meta分析检索PubMed、Cochrane和Embase数据库至2023年7月15日,纳入3项随机对照试验和3项倾向评分匹配队列研究,共21,402例成人(>16岁)非创伤性院外心脏骤停患者,比较碳酸氢钠组与对照组。主要结局短期生存率(包括自主循环恢复、存活至急诊科或入院)两组无差异(OR=1.04;95%CI 0.98-1.12;P=0.21)。次要结局长期生存率(出院存活和1个月神经功能良好存活)两组无差异(OR=0.82;95%CI 0.50-1.34;P=0.43)。敏感性分析去除一项研究后,碳酸氢钠组长期生存率低于对照组。作者结论认为碳酸氢钠与短期和长期生存率均无关联,甚至可能恶化长期生存。
要点
- 成人(>16岁)非创伤性院外心脏骤停患者中,碳酸氢钠组与对照组短期生存率无差异(OR=1.04;95%CI 0.98-1.12;P=0.21)。
- 长期生存率两组无差异(OR=0.82;95%CI 0.50-1.34;P=0.43),但异质性高(I²=80%)。
- 敏感性分析去除一项研究后,碳酸氢钠组长期生存率低于对照组。
- 作者结论:碳酸氢钠与短期和长期生存率均无关联,甚至可能恶化长期生存。
适用人群与场景
- 成人(>16岁)非创伤性院外心脏骤停患者,碳酸氢钠组与对照组有明确比较。
研究设计与关键结果
- 系统评价与Meta分析纳入6项研究(3项随机对照试验和3项倾向评分匹配研究),共21,402例患者。
- 主要结局短期生存率(包括自主循环恢复、存活至急诊科或入院)两组无差异(OR=1.04;95%CI 0.98-1.12;P=0.21;χ²=6.68;I²=25%)。
- 次要结局长期生存率(出院存活和1个月神经功能良好存活)两组无差异(OR=0.82;95%CI 0.50-1.34;P=0.43;χ²=14.96;I²=80%)。
- 敏感性分析去除一项研究后,碳酸氢钠组长期生存率低于对照组。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入随机对照试验和倾向评分匹配队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在院外心脏骤停患者中,碳酸氢钠给药与短期生存率和长期生存率均无关联,甚至可能恶化长期生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Evidence on the efficacy of sodium bicarbonate (SB) in out-of-hospital cardiac arrest (OHCA) is controversial and generally of low quality. A systematic review and meta-analysis was performed to evaluate the effect of SB in OHCA patients based on randomized controlled trial (RCT) and propensity score matching (PSM) cohort studies.
METHODS: We searched the PubMed, Cochrane, and Embase databases for RCTs and PSM cohort studies from inception to July 15, 2023. We included studies involving adult (>16 years) no-trauma OHCA patients with clear comparisons between the Bicarbonate group and Control group. All studies reported our primary outcome of short-term survival rate included ROSC and survival to emergency department or hospital admission or secondary outcome of long-term survival rate included survival at hospital discharge and good neurologic survival at 1 month. Results were expressed as odds ratio (OR) with accompanying 95% confidence interval (CI). To reduce bias, we performed a subgroup analysis of RCTs and PSM cohort studies. Also, we performed sensitivity analysis to resolve the heterogeneity.
RESULTS: Six studies (3 RCTs and 3 PSMs) comprising 21,402 patients were included. The primary outcome of this meta-analysis showed that short-term survival rate between the two groups was no difference (OR = 1.04; 95% CI, 0.98 to 1.12; P = 0.21; χ2 = 6.68; I2 = 25%). Secondary outcome demonstrated that long -term survival rate between the two groups was no difference (OR = 0.82; 95% CI, 0.50 to 1.34; P = 0.43; χ2 = 14.96; I2 = 80%). A sensitive analysis was performed by removing one study showed long-term survival rate of the Bicarbonate group was lower than that of the Control group.
CONCLUSIONS: In patients with OHCA, sodium bicarbonate administration was associated neither with short-term survival rate nor with long-term survival rate, it may even worsen the long-term survival.
参考来源
- Xu T, Wu C, Shen Q, et al. The effect of sodium bicarbonate on OHCA patients: A systematic review and meta-analysis of RCT and propensity score studies. Am J Emerg Med. 2023. PMID: 37611525. doi:10.1016/j.ajem.2023.08.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。